Laquer V, Parra V, Lacour JP, Takahashi H, et al. IL-33 antibody failed to demonstrate benefit in a phase 2 double-blind, randomised placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis. Br J Dermatol 2022 Apr 28. doi: 10.1111/bjd.21631.
PMID: 35481678